Abiomed, Inc. ABMDtoday announced the appointment of Paul G. Thomas to the Company's Board of Directors.
Currently, Mr. Thomas is Chief Executive Officer and Founder of Roka Bioscience, a company focused on the development and commercialization of molecular assays and is a Director of Orthovita, Inc. VITA.
Mr. Thomas previously served as Chairman, Chief Executive Officer and President of LifeCell Corporation until it was acquired by KCI in 2008 and also held various senior positions during his tenure of 15 years with Ohmeda.
Mr. Thomas received his M.B.A. degree from Columbia University Graduate School of Business, completed his postgraduate studies in Chemistry at the University of Georgia Graduate School of Arts and Science and received his B.S. degree in Chemistry from St. Michael's College in Vermont.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in